25 / 27
Page 67
Volume 09
Journal of Alzheimers Disease & Parkinsonism
ISSN: 2161-0460
Epilepsy 2019
Parkinsons Congress 2019
August 29-31, 2019
JOINT EVENT
conferenceseries
.com
August 29-31, 2019 Vienna, Austria
&
5
th
International Conference on
Epilepsy & Treatment
5
th
World Congress on
Parkinsons & Huntington Disease
Neurobiology of epilepsy and epilepsy case report
Chencho Dorji
Khesar Gyalpo University of Medical Sciences, Bhutan
Background:
Wide treatment gap in epilepsy prevails in developing countries like Bhutan due to lack of awareness,
stigma, shame, discrimination among patients and lack of adequate treatment services. It is estimated that less than
20 % (n=1000) of epilepsy patients (n=5000) in Bhutan are receibing treatment at prsent. Not much information on
epilepsy are avaialble.
Policy and Strategy:
Bhutan has opted a policy of community-based epilepsymanagement through a strategy of using
the existing primary health care infrastructure by training primary health care workers on epilepsy management and
providing basic essential anti-epileptic drugs free of charge to patients.
Program Activity:
Primary Health workers are trained to diagnose and treat epilepsy cases with limited anti-
epileptic drugs. Difficult and complicated cases are referred to specialists at referral hospitals for confirmation of
diagnosis and initiation of treatment. Majority of the patients are sent back to the primary health care for follow up
and long term contimuation of treatment.
Findings:
Almost all the cases are screened by the only MRI Brain Scan Machine and two CT Scan Machines
available at the two Referral Hospitals in Bhutan. Out of 1000 patients scanned, we found 170 (17 %) showed NCC
in their brain. We are going to highlight this presentation by discussing the management of repeated re-infection of
case of NCC with Epilepsy inspite of treatment.
Discussion:
It is well known that NCCcauses epilepsy and that NCC responds to anti-parasitic drugs likeAlbendazole.
However, in one case that we observed, there was repeated re-infection or reemergence of NCC associated with
recurrence of seizure in spite of repeated administration of Albendazole.
Conclusion:
NCC is a significant contributor to epilepsy in the developing world and needs to be screened and
treated.
J Alzheimers Dis Parkinsonism 2019, Volume 09